| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Scientific Officer | EVP, Research &Investments
1 company
Reddoch James F. is an EVP &Chief Scientific Officer at Royalty Pharma plc. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $41.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 2022 | RPRX Royalty Pharma Plc | EVP &Chief Scientific Officer | Sell | 100,000 | $41.23 | $4,122,670.00 | -10.9% | -4.5% | -34.8% | |
| Jun 8, 2022 | RPRX Royalty Pharma Plc | EVP &Chief Scientific Officer | Sell | 100,000 | $41.56 | $4,155,900.00 | -9.8% | +1.4% | -16.0% | |
| May 27, 2022 | RPRX Royalty Pharma Plc | EVP &Chief Scientific Officer | Sell | 75,000 | $41.08 | $3,081,007.50 | -6.8% | +6.2% | -20.9% | |
| May 19, 2022 | RPRX Royalty Pharma Plc | EVP &Chief Scientific Officer | Sell | 75,000 | $40.44 | $3,033,127.50 | -6.4% | +12.2% | -14.5% | |
| Jul 26, 2021 | RPRX Royalty Pharma Plc | EVP, Research &Investments | Sell | 8,949 | $39.78 | $355,976.90 | -0.8% | -4.7% | +10.3% | |
| Jul 26, 2021 | RPRX Royalty Pharma Plc | EVP, Research &Investments | Sell | 8,949 | $39.78 | $355,976.90 | -0.8% | -4.7% | +10.3% | |
| Jul 14, 2021 | RPRX Royalty Pharma Plc | EVP, Research &Investments | Sell | 17,934 | $42.01 | $753,369.31 | -0.5% | -11.6% | +7.2% | |
| Jul 8, 2021 | RPRX Royalty Pharma Plc | EVP, Research &Investments | Sell | 73,117 | $42.19 | $3,085,026.93 | -1.9% | -13.5% | +5.7% | |
| Jun 8, 2021 | RPRX Royalty Pharma Plc | EVP, Research &Investments | Sell | 200,000 | $45.55 | $9,110,689.25 | -3.6% | -15.7% | -9.1% | |
| Jun 2, 2021 | RPRX Royalty Pharma Plc | EVP, Research &Investments | Sell | 50,000 | $42.13 | $2,106,560.00 | -3.3% | -9.7% | -3.9% |